Wegovy set to launch in Canada. What to know about the weight-loss drug
Related Articles
-
Weight-loss drug startup Metsera wants to take on Novo and Lilly. Here's what you need to know
Metsera, a clinical-stage biotechnology startup that develops drugs for obesity and metabolic diseases, launched on Thursday with what it described as a “broad portfolio” of weight-loss treatments that it hopes to bring to market. The company, which has already acquired the U.K.-based startup, Zihipp, and formed a licensing pact with a South Korean drugmaker, D&D Pharmatech, claims that its products could eventually compete with industry leaders Novo Nordisk’s Wegovy and Eli Lilly’s Mounjaro....
-
How weight-loss drugs are changing the diet industry
Ever since college, Brad Jobling struggled with his weight, fluctuating between a low of 155 pounds when he was in his thirties to as high as 220. He spent a decade tracking calories on WeightWatchers, but the pounds he dropped always crept back onto his 5-foot-5-inch frame. A little over a year ago, the 58-year-old Manhattan resident went on a new weight loss drug called Wegovy. He’s lost 30 pounds, and has started eating healthier food and exercising—the habits behind many commercial diet...
-
Extra Extra: Don't buy weight loss drugs from TikTok
Because it's best to get your medication from a doctor, here are your afternoon links: a push for dog poop bags, a chance to live in a decked out Skittles apartment, why Cher dates young men, and more from around the city and internet. [ more › ]